<DOC>
	<DOCNO>NCT00234078</DOCNO>
	<brief_summary>The purpose study evaluate dose-response OPC-12759 ophthalmic suspension dry eye patient .</brief_summary>
	<brief_title>Dose-response Study OPC-12759 Ophthalmic Suspension</brief_title>
	<detailed_description />
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<criteria>1 . Outpatient . 2 . Subjective complaint dry eye present minimum 20 month . 3 . Primary ocular discomfort severity moderate severe . 4 . Corneal conjunctival damage moderate severe . 5 . Unanesthetized Schirmer 's test score 7mm/5minutes less . 6 . Best correct visual acuity 0.2 good eye . 1 . Presence anterior segment disease disorder associate keratoconjunctivitis sicca . 2 . Anticipated use topicallyinstilled ocular medication patient discontinue use study . 3 . Anticipated use contact lens study . 4 . Any history ocular surgery within 12 month . 5 . Female patient pregnant , possibly pregnant breast feeding ; 6 . Known hypersensitivity component study drug procedural medication . 7 . Receipt investigational product within 4 month .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>OPC-12759</keyword>
	<keyword>Dry eye syndrome</keyword>
</DOC>